A Phase 2, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Four-Arm Trial to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo for the Treatment of Abdominal Pain in Patients With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D).
Phase of Trial: Phase II
Latest Information Update: 16 Jul 2010
At a glance
- Drugs RVX 100 (Primary)
- Indications Abdominal pain; Irritable bowel syndrome
- Focus Therapeutic Use
- 13 May 2010 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 13 May 2010 Planned end date changed from 1 Oct 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov.
- 22 Apr 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.